These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Jersey
|
22-1441806
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
One Branca Road
East Rutherford, NJ 07073
|
|
(Address of principal executive offices)
|
|
(201) 933-1600
|
|
(Registrant’s telephone number, including area code)
|
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
ý
|
|
PART I – FINANCIAL INFORMATION
|
||
|
Page
|
||
|
Item 1.
|
||
|
3
|
||
|
Item 2.
|
||
|
14
|
||
|
Item 3.
|
||
|
18
|
||
|
Item 4.
|
||
|
18
|
||
|
PART II – OTHER INFORMATION
|
||
|
Item 1.
|
19
|
|
|
Item 1A.
|
19
|
|
|
Item 2.
|
19
|
|
|
Item 3.
|
19
|
|
|
Item 4.
|
19
|
|
|
Item 5.
|
19
|
|
|
Item 6.
|
20
|
|
|
21
|
||
|
June 30, 2012
|
March 31, 2012
|
|||||||
|
(unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
166,674
|
413,195
|
|||||
|
Accounts receivable, net
|
539,446
|
1,694,636
|
||||||
|
Unbilled government receivables
|
1,768,208
|
1,780,381
|
||||||
|
Inventories, net
|
7,101,996
|
5,023,975
|
||||||
|
Prepaid expenses and other
|
134,587
|
220,255
|
||||||
|
Deferred debt expense
|
108,321
|
108,321
|
||||||
|
Deferred income tax asset
|
1,288,631
|
1,288,631
|
||||||
|
Total current assets
|
11,107,863
|
10,529,394
|
||||||
|
Equipment and leasehold improvements, net
|
654,287
|
706,870
|
||||||
|
Deferred debt expenses – long-term
|
237,704
|
264,784
|
||||||
|
Deferred income tax asset – non-current
|
1,112,334
|
948,489
|
||||||
|
Other assets
|
56,872
|
56,872
|
||||||
|
Total assets
|
$
|
13,169,060
|
$
|
12,506,409
|
||||
|
LIABILITIES & STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Current portion long-term debt
|
605,492
|
542,382
|
||||||
|
Capital lease obligations
|
67,921
|
64,675
|
||||||
|
Accounts payable
|
3,821,297
|
2,850,432
|
||||||
|
Deferred revenues – current portion
|
25,765
|
34,767
|
||||||
|
Accrued payroll, vacation pay and payroll taxes
|
484,585
|
440,116
|
||||||
|
Accrued expenses
|
2,615,472
|
2,074,911
|
||||||
|
Total current liabilities
|
7,620,532
|
6,007,283
|
||||||
|
Subordinated notes payable-related parties, net of debt discount
|
250,000
|
250,000
|
||||||
|
Capital Lease Obligations
|
131,910
|
149,582
|
||||||
|
Deferred revenues
|
3,470
|
4,637
|
||||||
|
Warranty Liability
|
105,896
|
355,290
|
||||||
|
Long-term debt, net of debt discount
|
1,355,525
|
1,490,302
|
||||||
|
Total liabilities
|
9,467,333
|
8,257,094
|
||||||
|
Commitments
|
||||||||
|
Stockholders' equity:
|
||||||||
|
Common stock, par value $.10 per share, 2,710,715 and
2,646,215 issued and outstanding as of June 30,
2012 and March 31, 2012, respectively
|
271,071
|
268,421
|
||||||
|
Additional paid-in capital
|
6,040,003
|
5,921,441
|
||||||
|
Accumulated deficit
|
(2,609,347
|
)
|
(1,940,547
|
)
|
||||
|
Total stockholders' equity
|
3,701,727
|
4,249,315
|
||||||
|
Total liabilities and stockholders' equity
|
$
|
13,169,060
|
$
|
12,506,409
|
||||
| Three Months Ended | ||||||||
|
June 30, 2012
|
June 30, 2011
|
|||||||
|
(Restated)
|
||||||||
|
Net sales
|
$
|
1,177,288
|
$
|
3,990,211
|
||||
|
Cost of sales
|
893,594
|
2,128,580
|
||||||
|
Gross margin
|
283,694
|
1,861,631
|
||||||
|
Operating expenses:
|
||||||||
|
Selling, general and administrative
|
653,888
|
798,822
|
||||||
|
Engineering, research and development
|
578,604
|
849,038
|
||||||
|
Total operating expenses
|
1,232,492
|
1,647,860
|
||||||
|
Income (loss) from operations
|
(948,798)
|
213,771
|
||||||
|
Other income (expense):
|
||||||||
|
Amortization of debt discount
|
(13,392
|
)
|
(13,395
|
)
|
||||
|
Amortization of debt expense
|
(27,080
|
)
|
(27,080
|
)
|
||||
|
Change in fair value of common stock warrants
|
249,394
|
(168,586
|
)
|
|||||
|
Proceeds from life insurance policy
|
-
|
300,029
|
||||||
|
Interest income
|
-
|
93
|
||||||
|
Interest expense
|
(92,468
|
)
|
(102,694
|
)
|
||||
|
Total other income (expense)
|
116,454
|
(11,633
|
)
|
|||||
|
Income (loss) before income taxes
|
(832,344
|
)
|
202,138
|
|||||
|
Income tax provision (benefit)
|
(163,544
|
)
|
282,933
|
|||||
|
Net loss
|
$
|
(668,800
|
)
|
$
|
(80,795
|
)
|
||
|
Net loss per share:
|
||||||||
|
Basic loss per common share
|
$
|
(0.25
|
)
|
$
|
(0.03
|
)
|
||
|
Diluted loss per common share
|
$
|
(0.25
|
)
|
$
|
(0.03
|
)
|
||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
2,698,984
|
2,647,138
|
||||||
|
Diluted
|
2,698,984
|
2,647,138
|
||||||
|
Three months ended
|
||||||||
|
June 30,
2012
|
June 30,
2011
|
|||||||
|
(Restated)
|
||||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(668,800
|
)
|
$
|
(80,795
|
)
|
||
|
Adjustments to reconcile net income (loss) to net cash provided by
(used in) operating activities:
|
||||||||
|
Deferred income taxes
|
(163,845
|
)
|
282,017
|
|||||
|
Depreciation and amortization
|
53,231
|
29,881
|
||||||
|
Provision for inventory obsolescence
|
-
|
10,000
|
||||||
|
Amortization of debt discount
|
13,392
|
13,395
|
||||||
|
Amortization of debt expense
|
27,080
|
27,080
|
||||||
|
Increase in cash surrender value of life insurance
|
-
|
2,011
|
||||||
|
Proceeds from life insurance policy
|
-
|
(300,029
|
)
|
|||||
|
Change in fair value of common stock warrant
|
(249,394
|
)
|
168,586
|
|||||
|
Non-cash stock-based compensation
|
22,277
|
24,231
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Decrease in accounts receivable
|
1,155,190
|
870,875
|
||||||
|
Decrease in unbilled government receivables
|
12,173
|
-
|
||||||
|
(Increase) decrease in inventories
|
(2,078,021
|
)
|
439,886
|
|||||
|
Decrease (increase) in prepaid expenses & other
|
85,668
|
(3,569
|
)
|
|||||
|
Increase in other assets
|
-
|
(32,316
|
)
|
|||||
|
Increase (decrease) in accounts payable
|
970,865
|
(868,418
|
)
|
|||||
|
(Decrease) increase in accrued payroll, vacation pay & withholdings
|
44,469
|
(1,381)
|
||||||
|
Decrease in deferred revenues
|
(10,169
|
)
|
(13,276
|
)
|
||||
|
Decrease increase in progress billings
|
-
|
(424,202
|
)
|
|||||
|
Increase in accrued expenses
|
540,561
|
164,353
|
||||||
|
Net cash (used in) provided by operating activities
|
(245,323
|
)
|
308,329
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of equipment
|
(648
|
)
|
-
|
|||||
|
Net cash used in investing activities
|
(648
|
)
|
-
|
|||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from the exercise of stock options
|
98,935
|
5,390
|
||||||
|
Repayment of long-term debt
|
(85,059
|
)
|
-
|
|||||
|
Repayment of capitalized lease obligations
|
(14,426
|
)
|
(8,332
|
)
|
||||
|
Proceeds from life insurance policy
|
-
|
285,981
|
||||||
|
Net cash (used in) provided by financing activities
|
(550
|
)
|
283,039
|
|||||
|
Net (decrease) increase in cash and cash equivalents
|
(246,521
|
)
|
591,368
|
|||||
|
Cash and cash equivalents at beginning of period
|
413,195
|
123,955
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
166,674
|
$
|
715,323
|
||||
|
Taxes paid
|
$
|
-
|
$
|
-
|
||||
|
Interest paid
|
$
|
83,809
|
$
|
87,192
|
||||
|
June 30,
2012
|
March 31,
2012
|
|||||||
|
Government
|
$
|
238,513
|
$
|
1,272,436
|
||||
|
Commercial
|
336,403
|
457,670
|
||||||
|
Less: Allowance for doubtful accounts
|
(35,470
|
)
|
(35,470
|
)
|
||||
|
$
|
539,446
|
$
|
1,694,636
|
|||||
|
June 30,
2012
|
March 31,
2012
|
|||||||
|
Purchased parts
|
$
|
5,292,049
|
$
|
3,452,832
|
||||
|
Work-in-process
|
1,982,159
|
1,725,395
|
||||||
|
Finished goods
|
27,788
|
45,748
|
||||||
|
Less: Inventory reserve
|
(200,000
|
)
|
(200,000
|
)
|
||||
|
$
|
7,101,996
|
$
|
5,023,975
|
|||||
|
Three Months Ended
|
Three Months Ended
|
|||||||
|
June 30,
2012
|
June 30,
2011
(Restated)
|
|||||||
|
Basic net loss per share computation:
|
||||||||
|
Net loss attributable to common stockholders
|
$
|
(668,800
|
)
|
$
|
(80,795
|
)
|
||
|
Weighted-average common shares outstanding
|
2,698,984
|
2,647,138
|
||||||
|
Basic net loss per share attributable to common stockholders
|
$
|
(0.25
|
)
|
$
|
(0.03
|
)
|
||
|
Diluted net loss per share computation
|
||||||||
|
Net loss attributable to common stockholders
|
$
|
(668,800
|
)
|
$
|
(80,795
|
)
|
||
|
Weighted-average common shares outstanding
|
2,698,984
|
2,647,138
|
||||||
|
Incremental shares attributable to the assumed exercise of outstanding stock options
|
-
|
-
|
||||||
|
Total adjusted weighted-average shares
|
2,698,984
|
2,647,138
|
||||||
|
Diluted net loss per share attributable to common stockholders
|
$
|
(0.25
|
)
|
$
|
(0.03
|
)
|
||
|
(1)
|
The Note has a term of five (5) years with an annual interest rate of 14% on the outstanding principal amount. Payments for the first year were interest only and amounted to $28,762 monthly. In September 2011, the Company began making monthly payments of approximately $69,000 for interest and principal for the remaining term of the loan.
|
|
(2)
|
The Company issued BCA a nine-year warrant for 136,090 shares, based upon 4.5% of the fully-diluted outstanding shares of the Company’s common stock exercisable at $6.70 per share, the average closing price of the common stock over the three days preceding the loan closing on the NYSE-Mkt Exchange. In the event of specific major corporate events or the maturity of the five-year loan, BCA can require the Company to purchase the warrant and warrant shares at the higher of the then Exchange market price less the share exercise price, in the case of the purchase of the warrant, or five times operating income per share. In connection with the warrant issued in conjunction with this debt, the Company recorded a debt discount and warrant liability, which is being marked to fair value at the end of each period (see Note 10 to Notes to the Condensed Consolidated Financial Statements). The debt discount is to be amortized over the life of the loan.
|
|
(3)
|
Loan provisions also contain customary representations and warranties.
|
|
(4)
|
BCA has a lien on all of the Company’s assets. In February 2011, BCA agreed to release part of its lien on Company assets to the U.S. Government to allow for progress billings up to $1,000,000.
|
|
(5)
|
The Company may prepay a portion of the principal amount provided that (i) any such prepayment shall be applied in the inverse order of the maturity of the principal amount of the Note, (ii) the Company shall pay to BCA an additional amount equal to (A) 3% of the outstanding principal amount being prepaid if such prepayment is made during the first loan year, and (B) 2% of the outstanding principal amount then being prepaid if such prepayment is being made during the second loan year. Each payment must be not less than $25,000 or multiples of $25,000 in excess thereof.
|
|
(6)
|
Upon the occurrence of a Change of Control (as defined in the Agreement) or within five (5) Business Days of an O’Hara Life Insurance Realization Event (as defined in the Agreement), the Company shall, in each case at the election of BCA, prepay by wire transfer the entire outstanding principal amount of the Note in accordance with the redemption prices (the “Mandatory Redemption Prices”) set forth below (expressed as a percentage of the outstanding principal amount being prepaid and shall pay 103% in the first year of the loan, 102% in the second year of the loan, and 100% thereafter), together with (x) Interest, if any, accrued and unpaid on the outstanding principal amount of the Note so prepaid through the date of such prepayment, (y) all reasonable out-of-pocket costs and expenses (including reasonable fees, charges and disbursements of counsel), if any, associated with such prepayment, and (z) all other costs, expenses and indemnities then payable under this Agreement (such amounts, collectively the “Mandatory Redemption Payment”). If a Change of Control or O’Hara Life Insurance Realization Event shall occur during any Loan Year set forth below, the Mandatory Redemption Price shall be determined based upon the percentage indicated above for such Loan Year multiplied by the principal amount which is being prepaid. At the election of BCA, all or any portion of the Mandatory Redemption Payment may be paid in the form of common stock of the Company in marketable condition in lieu of cash and to the extent available and to the extent not restricted by any SBIC Regulations. In the event BCA makes the election contemplated by the immediately preceding sentence, the Company shall issue to BCA that number of shares having an aggregate Current Market Price as of such issuance date equal to that portion of the Mandatory Redemption Payment subject to such election.
|
|
(7)
|
The Note contains a number of affirmative and negative covenants which restrict our operations. The BCA agreement contains a number of affirmative and negative covenants. For the quarter ended June 30, 2012, the Company was not in compliance with four covenants related to maintaining agreed upon financial ratios for fixed charges, leverage and debt service as well as a requirement for earnings before interest, taxes, depreciation and amortization (EBITDA). However, the Company received a waiver from BCA on each of the above mentioned covenants.
|
|
(8)
|
The Company and BCA have amended certain provisions to ease some restrictions.
|
|
Three Months Ended
|
Avionics
|
Avionics
|
Avionics
|
Corporate
|
|
|||||||||||||||
|
June 30, 2012
|
Gov’t
|
Comm’l.
|
Total
|
Items
|
Total
|
|||||||||||||||
|
Net sales
|
549,966 | 627,322 | 1,177,288 | - | 1,177,288 | |||||||||||||||
|
Cost of Sales
|
315,929 | 577,665 | 893,594 | - | 893,594 | |||||||||||||||
|
Gross Margin
|
234,037 | 49,657 | 283,694 | - | 283,694 | |||||||||||||||
|
Engineering, research, and d
evelopment
|
578,604 | 578,604 | ||||||||||||||||||
|
Selling, general, and admin.
|
316,989 | 336,899 | 653,888 | |||||||||||||||||
|
Amortization of debt discount
|
13,392 | 13,392 | ||||||||||||||||||
|
Amortization of debt expense
|
27,080 | 27,080 | ||||||||||||||||||
|
Change in fair value of
common stock warrants
|
(249,394 | ) | (249,393 | ) | ||||||||||||||||
|
Interest (income) expense, net
|
0 | 92,468 | 92,467 | |||||||||||||||||
|
Total expenses
|
895,593 | 220,445 | 1,116,038 | |||||||||||||||||
|
Loss before income
|
(611,899 | ) | (220,445 | ) | (832,344 | ) | ||||||||||||||
|
Three Months Ended
|
Avionics
|
Avionics
|
Avionics
|
Corporate
|
|
|||||||||||||||
|
June 30, 2011
|
Gov’t
|
Comm’l.
|
Total
|
Items
|
Total
|
|||||||||||||||
|
Net sales
|
3,145,592 | 844,619 | 3,990,211 | - | 3,990,211 | |||||||||||||||
|
Cost of Sales
|
1,674,813 | 453,767 | 2,128,580 | - | 2,128,580 | |||||||||||||||
|
Gross Margin
|
1,470,779 | 390,852 | 1,861,631 | - | 1,861,631 | |||||||||||||||
|
Engineering, research, and development
|
849,038 | 849,038 | ||||||||||||||||||
|
Selling, general, and admin.
|
361,816 | 437,006 | 798,822 | |||||||||||||||||
|
Amortization of debt discount
|
13,395 | 13,395 | ||||||||||||||||||
|
Amortization of debt expense
|
27,080 | 27,080 | ||||||||||||||||||
|
Change in fair value of
common stock warrants
|
168,586 | 168,586 | ||||||||||||||||||
|
Proceeds from life insurance
|
(300,029 | ) | (300,029 | ) | ||||||||||||||||
|
Interest (income) expense, net
|
- | 102,601 | 102,601 | |||||||||||||||||
|
Total expenses
|
1,210,854 | 448,639 | 1,659,493 | |||||||||||||||||
|
Income (loss) before income
|
650,777 | (448,639 | ) | 202,138 | ||||||||||||||||
|
·
|
Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
|
|
·
|
Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
|
|
·
|
Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
|
|
·
|
Market approach — Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
|
|
·
|
Income approach — Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method.
|
|
·
|
Cost approach — Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).
|
|
June 30, 2012
|
Level I
|
Level II
|
Level III
|
Total
|
||||||||||||
|
Total Assets
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||
|
Warrant liability
|
-
|
-
|
105,896
|
105,896
|
||||||||||||
|
Total Liabilities
|
$
|
-
|
$
|
-
|
$
|
105,896
|
$
|
105,896
|
||||||||
|
March 31, 2012
|
Level I
|
Level II
|
Level III
|
Total
|
||||||||||||
|
Total Assets
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||
|
Warrant liability
|
-
|
-
|
355,290
|
355,290
|
||||||||||||
|
Total Liabilities
|
$
|
-
|
$
|
-
|
$
|
355,290
|
$
|
355,290
|
||||||||
|
At Inception
|
March 31,
2012
|
June 30,
2012
|
||||||||||
|
Risk free interest rate
|
2.81
|
%
|
2.23
|
%
|
1.67
|
%
|
||||||
|
Expected life in years
|
9.00
|
7.45
|
7.20
|
|||||||||
|
Expected volatility
|
28.51
|
%
|
53.19
|
%
|
41.45
|
%
|
||||||
|
Fair market value per share
|
$
|
6.70
|
$
|
6.33
|
$
|
3.68
|
||||||
|
Exercise price
|
$
|
6.70
|
$
|
6.70
|
$
|
6.70
|
||||||
|
Warrant Liability
|
$
|
281,656
|
$
|
355,290
|
$
|
105,896
|
||||||
|
Exhibit No.
|
Description
|
|
|
4.1
|
||
|
10.1
|
||
|
10.2
|
||
|
10.3
|
||
|
10.4
|
||
|
10.5
|
||
|
31.1
|
||
|
31.2
|
||
|
32.1
|
||
|
32.2
|
||
|
101.INS
|
XBRL Instance Document**
|
|
|
101.SCH
|
Taxonomy Extension Schema Document**
|
|
|
101.CAL
|
Taxonomy Extension Calculation Linkbase Document**
|
|
|
101.DEF
|
Taxonomy Extension Definition Linkbase Document**
|
|
|
101.LAB
|
Taxonomy Extension Label Linkbase Document**
|
|
|
101.PRE
|
Taxonomy Extension Presentation Linkbase Document**
|
|
TEL-INSTRUMENT ELECTRONICS CORP.
|
|||||
|
Date: August 20, 2012
|
By:
|
/s/ Jeffrey C. O’Hara
|
|||
|
Name: Jeffrey C. O’Hara
|
|||||
|
Title: Chief Executive Officer
Principal Executive Officer
|
|||||
|
Date: August 20, 2012
|
By:
|
/s/ Joseph P. Macaluso
|
|||
|
Name: Joseph P. Macaluso
|
|||||
|
Title: Principal Financial Officer
Principal Accounting Officer
|
|||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|